Source: Malaria Journal. Unidade: FM
Subjects: CUSTO ECONÔMICO, MALÁRIA (EPIDEMIOLOGIA;QUIMIOTERAPIA), SURTOS DE DOENÇAS
ABNT
MASSAD, Eduardo et al. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Malaria Journal, v. 10, n. 130, 2011Tradução . . Disponível em: https://doi.org/10.1186/1475-2875-10-130. Acesso em: 06 out. 2024.APA
Massad, E., Behrens, B. C., Coutinho, F. A. B., & Behrens, R. H. (2011). Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Malaria Journal, 10( 130). doi:10.1186/1475-2875-10-130NLM
Massad E, Behrens BC, Coutinho FAB, Behrens RH. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries [Internet]. Malaria Journal. 2011 ; 10( 130):[citado 2024 out. 06 ] Available from: https://doi.org/10.1186/1475-2875-10-130Vancouver
Massad E, Behrens BC, Coutinho FAB, Behrens RH. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries [Internet]. Malaria Journal. 2011 ; 10( 130):[citado 2024 out. 06 ] Available from: https://doi.org/10.1186/1475-2875-10-130